DK Life Science Co., Ltd. (KOSDAQ:303810)
3,845.00
-25.00 (-0.65%)
At close: Dec 5, 2025
DK Life Science Revenue
DK Life Science had revenue of 29.44B KRW in the quarter ending September 30, 2025, a decrease of -9.17%. This brings the company's revenue in the last twelve months to 131.17B, up 0.95% year-over-year. In the year 2024, DK Life Science had annual revenue of 131.82B with 9.70% growth.
Revenue (ttm)
131.17B
Revenue Growth
+0.95%
P/S Ratio
0.94
Revenue / Employee
1.31B
Employees
100
Market Cap
122.98B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |